Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.

CONCLUSIONS: Our study provides evidence of the efficacy of the lercanidipine/enalapril combination in ameliorating hypertension-related target organ damage and in reducing sympathetic overdrive. PMID: 27779461 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/27779461?dopt=Abstract

Source: Current Medical Research and Opinion - October 27, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research

More News: Research